vs
PREFORMED LINE PRODUCTS CO（PLPC）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Sotera Health Coの直近四半期売上が大きい（$303.4M vs $173.1M、PREFORMED LINE PRODUCTS COの約1.8倍）。Sotera Health Coの純利益率が高く（11.5% vs 4.9%、差は6.6%）。Sotera Health Coの前年同期比売上増加率が高い（4.6% vs 3.6%）。Sotera Health Coの直近四半期フリーキャッシュフローが多い（$52.4M vs $11.8M）。過去8四半期でPREFORMED LINE PRODUCTS COの売上複合成長率が高い（10.8% vs 10.6%）
プリフォームド・ライン・プロダクツ社（PLPC）は、送配電、通信、再生可能エネルギーインフラ分野向けのエンジニアリングハードウェアや部品を設計・製造・供給し、世界各国の事業者にネットワークの信頼性と業務効率を高めるソリューションを提供している。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
PLPC vs SHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $173.1M | $303.4M |
| 純利益 | $8.4M | $34.8M |
| 粗利率 | 29.8% | 54.7% |
| 営業利益率 | 6.8% | 23.2% |
| 純利益率 | 4.9% | 11.5% |
| 売上前年比 | 3.6% | 4.6% |
| 純利益前年比 | -19.3% | 182.8% |
| EPS（希薄化後） | $1.72 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $173.1M | $303.4M | ||
| Q3 25 | $178.1M | $311.3M | ||
| Q2 25 | $169.6M | $294.3M | ||
| Q1 25 | $148.5M | $254.5M | ||
| Q4 24 | $167.1M | $290.2M | ||
| Q3 24 | $147.0M | $285.5M | ||
| Q2 24 | $138.7M | $276.6M | ||
| Q1 24 | $140.9M | $248.2M |
| Q4 25 | $8.4M | $34.8M | ||
| Q3 25 | $2.6M | $48.4M | ||
| Q2 25 | $12.7M | $8.0M | ||
| Q1 25 | $11.5M | $-13.3M | ||
| Q4 24 | $10.5M | $12.3M | ||
| Q3 24 | $7.7M | $17.0M | ||
| Q2 24 | $9.4M | $8.8M | ||
| Q1 24 | $9.6M | $6.3M |
| Q4 25 | 29.8% | 54.7% | ||
| Q3 25 | 29.7% | 57.0% | ||
| Q2 25 | 32.7% | 56.6% | ||
| Q1 25 | 32.8% | 53.2% | ||
| Q4 24 | 33.3% | 56.6% | ||
| Q3 24 | 31.1% | 55.4% | ||
| Q2 24 | 31.9% | 55.2% | ||
| Q1 24 | 31.3% | 51.2% |
| Q4 25 | 6.8% | 23.2% | ||
| Q3 25 | 7.4% | 23.4% | ||
| Q2 25 | 10.1% | 6.4% | ||
| Q1 25 | 8.8% | -5.8% | ||
| Q4 24 | 10.5% | 30.0% | ||
| Q3 24 | 7.1% | 28.2% | ||
| Q2 24 | 8.1% | 27.8% | ||
| Q1 24 | 8.2% | 21.4% |
| Q4 25 | 4.9% | 11.5% | ||
| Q3 25 | 1.5% | 15.5% | ||
| Q2 25 | 7.5% | 2.7% | ||
| Q1 25 | 7.8% | -5.2% | ||
| Q4 24 | 6.3% | 4.2% | ||
| Q3 24 | 5.2% | 6.0% | ||
| Q2 24 | 6.8% | 3.2% | ||
| Q1 24 | 6.8% | 2.5% |
| Q4 25 | $1.72 | $0.12 | ||
| Q3 25 | $0.53 | $0.17 | ||
| Q2 25 | $2.56 | $0.03 | ||
| Q1 25 | $2.33 | $-0.05 | ||
| Q4 24 | $2.13 | $0.05 | ||
| Q3 24 | $1.54 | $0.06 | ||
| Q2 24 | $1.89 | $0.03 | ||
| Q1 24 | $1.94 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $344.6M |
| 総負債低いほど良い | $38.3M | $2.1B |
| 株主資本純資産 | $475.5M | $606.0M |
| 総資産 | $653.6M | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.08× | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $344.6M | ||
| Q3 25 | — | $299.2M | ||
| Q2 25 | — | $332.4M | ||
| Q1 25 | — | $304.4M | ||
| Q4 24 | — | $277.2M | ||
| Q3 24 | — | $306.7M | ||
| Q2 24 | — | $246.1M | ||
| Q1 24 | — | $261.1M |
| Q4 25 | $38.3M | $2.1B | ||
| Q3 25 | $36.0M | $2.1B | ||
| Q2 25 | $31.8M | $2.2B | ||
| Q1 25 | $29.1M | $2.2B | ||
| Q4 24 | $20.8M | $2.2B | ||
| Q3 24 | $27.2M | $2.2B | ||
| Q2 24 | $31.6M | $2.2B | ||
| Q1 24 | $55.0M | $2.2B |
| Q4 25 | $475.5M | $606.0M | ||
| Q3 25 | $466.3M | $550.5M | ||
| Q2 25 | $460.7M | $511.3M | ||
| Q1 25 | $435.8M | $414.1M | ||
| Q4 24 | $422.3M | $404.9M | ||
| Q3 24 | $429.0M | $470.2M | ||
| Q2 24 | $416.2M | $422.8M | ||
| Q1 24 | $413.4M | $429.4M |
| Q4 25 | $653.6M | $3.3B | ||
| Q3 25 | $644.6M | $3.2B | ||
| Q2 25 | $631.5M | $3.2B | ||
| Q1 25 | $592.5M | $3.1B | ||
| Q4 24 | $573.9M | $3.1B | ||
| Q3 24 | $592.0M | $3.1B | ||
| Q2 24 | $572.6M | $3.1B | ||
| Q1 24 | $586.1M | $3.1B |
| Q4 25 | 0.08× | 3.53× | ||
| Q3 25 | 0.08× | 3.89× | ||
| Q2 25 | 0.07× | 4.34× | ||
| Q1 25 | 0.07× | 5.36× | ||
| Q4 24 | 0.05× | 5.49× | ||
| Q3 24 | 0.06× | 4.73× | ||
| Q2 24 | 0.08× | 5.26× | ||
| Q1 24 | 0.13× | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $21.9M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $11.8M | $52.4M |
| FCFマージンFCF / 売上 | 6.8% | 17.3% |
| 設備投資強度設備投資 / 売上 | 5.9% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 2.60× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $33.3M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $21.9M | $103.1M | ||
| Q3 25 | $18.9M | $71.2M | ||
| Q2 25 | $26.9M | $57.4M | ||
| Q1 25 | $5.7M | $55.5M | ||
| Q4 24 | $24.1M | $55.7M | ||
| Q3 24 | $9.4M | $97.5M | ||
| Q2 24 | $28.3M | $61.3M | ||
| Q1 24 | $5.8M | $9.7M |
| Q4 25 | $11.8M | $52.4M | ||
| Q3 25 | $8.3M | $35.0M | ||
| Q2 25 | $18.6M | $26.2M | ||
| Q1 25 | $-5.3M | $35.6M | ||
| Q4 24 | $20.6M | $-10.2M | ||
| Q3 24 | $5.8M | $61.1M | ||
| Q2 24 | $24.6M | $19.4M | ||
| Q1 24 | $1.8M | $-25.2M |
| Q4 25 | 6.8% | 17.3% | ||
| Q3 25 | 4.7% | 11.2% | ||
| Q2 25 | 10.9% | 8.9% | ||
| Q1 25 | -3.6% | 14.0% | ||
| Q4 24 | 12.3% | -3.5% | ||
| Q3 24 | 3.9% | 21.4% | ||
| Q2 24 | 17.7% | 7.0% | ||
| Q1 24 | 1.3% | -10.2% |
| Q4 25 | 5.9% | 16.7% | ||
| Q3 25 | 6.0% | 11.6% | ||
| Q2 25 | 4.9% | 10.6% | ||
| Q1 25 | 7.4% | 7.8% | ||
| Q4 24 | 2.1% | 22.7% | ||
| Q3 24 | 2.4% | 12.7% | ||
| Q2 24 | 2.7% | 15.2% | ||
| Q1 24 | 2.8% | 14.1% |
| Q4 25 | 2.60× | 2.96× | ||
| Q3 25 | 7.21× | 1.47× | ||
| Q2 25 | 2.12× | 7.21× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 2.30× | 4.52× | ||
| Q3 24 | 1.22× | 5.73× | ||
| Q2 24 | 3.02× | 7.00× | ||
| Q1 24 | 0.60× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PLPC
セグメントデータなし
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
